Clinical Trial Update: Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the impact of low-dose oral contraceptive therapy on hyperandrogenism in women with Polycystic Ovary Syndrome and examined how body ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Combined oral contraceptive therapy (combined oral contraceptive)

Snippet

Sponsor: Woman's | Conditions: Polycystic Ovary Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2017-03-31